The Latest in Dermatology

Expert Highlights Biologics in the Pipeline for Atopic Dermatitis

January 4, 2024

Dermatology

US Dermatologic Drug Approvals Rose Between 2012 and 2022

January 4, 2024

Dermatology

Public Citizen seeks stronger warning for Botox, related products

January 3, 2024

Experimental Topical Drug Shows Promise for Atopic Dermatitis and Plaque Psoriasis

December 28, 2023

Dermatology

Expert Frames Factors to Consider Among Atopic Dermatitis Treatment Options

December 27, 2023

Dermatology

‘Milestone’ Study Zeros in on 5-Year Safety Data From Upadacitinib Trials

December 26, 2023

‘Real-World’ Registry Study of Upadacitinib Supports Clinical Trial Data

December 22, 2023

Dermatology

What Makes Patients Vulnerable to Delusions of Parasitosis?

December 22, 2023

FDA Approves Topical Gel For Wounds Associated With JEB and DEB

December 22, 2023

Paradoxical Eczema Risk Low With Biologic Psoriasis Treatments

December 20, 2023

Dermatology

How to Reduce Cardiovascular Morbidity and Mortality in Psoriasis and PsA

December 19, 2023

Roflumilast foam gets nod as new option for seborrheic dermatitis

December 18, 2023

A 55-year-old female presented a with few years' history of pruritic plaques on her shins and wrists

December 15, 2023

Dermatology

How does lebrikizumab perform across different racial and ethnic subgroups?

December 15, 2023

Pilot study educates barbers about pseudofolliculitis barbae

December 15, 2023